Caxton Associates LP Intercept Pharmaceuticals, Inc. Transaction History

Caxton Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $111,266 - $192,784	8,880 Added 11.58%	85,544 $1.15 Million
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $66,107 - $91,730	-5,694 Reduced 6.91%	76,664 $948,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $484,798 - $782,188	39,705 Added 93.09%	82,358 $1.15 Million
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $179,425 - $238,741	-13,420 Reduced 23.93%	42,653 $694,000
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $800,722 - $1.1 Million	56,073 New	56,073 $913,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.